IDEAS home Printed from https://ideas.repec.org/a/eee/jhecon/v91y2023ics0167629623000516.html
   My bibliography  Save this article

The effects of becoming a physician on prescription drug use and mental health treatment

Author

Listed:
  • Mark Anderson, D.
  • Diris, Ron
  • Montizaan, Raymond
  • Rees, Daniel I.

Abstract

There is evidence that physicians disproportionately suffer from substance use disorder and mental health problems. It is not clear, however, whether these phenomena are causal. We use data on Dutch medical school applicants to examine the effects of becoming a physician on prescription drug use and the receipt of treatment from a mental health facility. Leveraging variation from lottery outcomes that determine admission into medical schools, we find that becoming a physician increases the use of antidepressants, anxiolytics, opioids, and sedatives. Increases in the use of antidepressants, anxiolytics, and sedatives are larger among female physicians than among their male counterparts.

Suggested Citation

  • Mark Anderson, D. & Diris, Ron & Montizaan, Raymond & Rees, Daniel I., 2023. "The effects of becoming a physician on prescription drug use and mental health treatment," Journal of Health Economics, Elsevier, vol. 91(C).
    • Handle: RePEc:eee:jhecon:v:91:y:2023:i:c:s0167629623000516
    DOI: 10.1016/j.jhealeco.2023.102774
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0167629623000516
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.jhealeco.2023.102774?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to look for a different version below or search for a different version of it.

    Other versions of this item:

    References listed on IDEAS

    as
    1. Karpinski, Ruth I. & Kinase Kolb, Audrey M. & Tetreault, Nicole A. & Borowski, Thomas B., 2018. "High intelligence: A risk factor for psychological and physiological overexcitabilities," Intelligence, Elsevier, vol. 66(C), pages 8-23.
    2. Leuven, Edwin & Oosterbeek, Hessel & de Wolf, Inge, 2013. "The effects of medical school on health outcomes: Evidence from admission lotteries," Journal of Health Economics, Elsevier, vol. 32(4), pages 698-707.
    3. Sacks, Daniel W. & Hollingsworth, Alex & Nguyen, Thuy & Simon, Kosali, 2021. "Can policy affect initiation of addictive substance use? Evidence from opioid prescribing," Journal of Health Economics, Elsevier, vol. 76(C).
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Michelle Acampora & Francesco Capozza & Vahid Moghani, 2022. "Mental Health Literacy, Beliefs and Demand for Mental Health Support among University Students," Tinbergen Institute Discussion Papers 22-079/I, Tinbergen Institute.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Cornoldi, Cesare & Giofrè, David & Toffalini, Enrico, 2023. "Cognitive characteristics of intellectually gifted children with a diagnosis of ADHD," Intelligence, Elsevier, vol. 97(C).
    2. Guez, Ava & Peyre, Hugo & Le Cam, Marion & Gauvrit, Nicolas & Ramus, Franck, 2018. "Are high-IQ students more at risk of school failure?," Intelligence, Elsevier, vol. 71(C), pages 32-40.
    3. Amy Finkelstein & Petra Persson & Maria Polyakova & Jesse M. Shapiro, 2022. "A Taste of Their Own Medicine: Guideline Adherence and Access to Expertise," American Economic Review: Insights, American Economic Association, vol. 4(4), pages 507-526, December.
    4. William Encinosa & Didem Bernard & Thomas M. Selden, 2022. "Opioid and non-opioid analgesic prescribing before and after the CDC’s 2016 opioid guideline," International Journal of Health Economics and Management, Springer, vol. 22(1), pages 1-52, March.
    5. Bhashkar Mazumder, 2023. "The Effects of Prescription Drug Monitoring Programs on Labor Market Activity and Credit Outcomes," Working Paper Series WP 2023-13, Federal Reserve Bank of Chicago.
    6. Simone Balestra & Helge Liebert & Nicole Maestas & Tisamarie B. Sherry, 2021. "Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic," NBER Working Papers 29596, National Bureau of Economic Research, Inc.
    7. Simone Balestra & Aurélien Sallin & Stefan C. Wolter, 2023. "High-Ability Influencers? The Heterogeneous Effects of Gifted Classmates," Journal of Human Resources, University of Wisconsin Press, vol. 58(2), pages 633-665.
    8. Alice M. Ellyson & Jevay Grooms & Alberto Ortega, 2022. "Flipping the script: The effects of opioid prescription monitoring on specialty‐specific provider behavior," Health Economics, John Wiley & Sons, Ltd., vol. 31(2), pages 297-341, February.
    9. Chen, Stacey H. & Chen, Jennjou & Chuang, Hongwei & Lin, Tzu-Hsin, 2023. "Physicians Treating Physicians: Relational and Informational Advantages in Treatment and Survival," IZA Discussion Papers 16048, Institute of Labor Economics (IZA).
    10. Lange-Küttner, Christiane & Averbeck, Bruno B. & Hentschel, Maren & Baumbach, Jan, 2021. "Intelligence matters for stochastic feedback processing during sequence learning in adolescents and young adults," Intelligence, Elsevier, vol. 86(C).
    11. Shevchenko, Victoria & Labouret, Ghislaine & Guez, Ava & Côté, Sylvana & Heude, Barbara & Peyre, Hugo & Ramus, Franck, 2023. "Relations between intelligence index score discrepancies and psychopathology symptoms in the EDEN mother-child birth cohort," Intelligence, Elsevier, vol. 98(C).
    12. Broten, Nicholas & Dworsky, Michael & Powell, David, 2022. "Do temporary workers experience additional employment and earnings risk after workplace injuries?," Journal of Public Economics, Elsevier, vol. 209(C).
    13. Bruton, Oliver J., 2021. "Is there a “g-neuron”? Establishing a systematic link between general intelligence (g) and the von Economo neuron," Intelligence, Elsevier, vol. 86(C).
    14. David Cho & Alvaro Mezza & Joshua Montes, 2022. "Choices and Implications when Measuring the Local Supply of Prescription Opioids," Finance and Economics Discussion Series 2022-078, Board of Governors of the Federal Reserve System (U.S.).
    15. Aniel Jessica Leticia Brambila-Tapia & Aris Judit Miranda-Lavastida & Nancy Araceli Vázquez-Sánchez & Nancy Lizbeth Franco-López & Martha Catalina Pérez-González & Gonzalo Nava-Bustos & Francisco José, 2022. "Association of Health and Psychological Factors with Academic Achievement and Non-Verbal Intelligence in University Students with Low Academic Performance: The Influence of Sex," IJERPH, MDPI, vol. 19(8), pages 1-12, April.
    16. Johanna Catherine Maclean & Justine Mallatt & Christopher J. Ruhm & Kosali Simon, 2022. "The Opioid Crisis, Health, Healthcare, and Crime: A Review of Quasi-Experimental Economic Studies," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 15-49, September.
    17. David Cho & Daniel I. García & Joshua Montes & Alison E. Weingarden, 2021. "Labor Market Effects of the Oxycodone-Heroin Epidemic," Finance and Economics Discussion Series 2021-025, Board of Governors of the Federal Reserve System (U.S.).
    18. Sumedha Gupta & Thuy D. Nguyen & Patricia R. Freeman & Kosali I. Simon, 2020. "Competitive Effects of Federal and State Opioid Restrictions: Evidence from the Controlled Substance Laws," NBER Working Papers 27520, National Bureau of Economic Research, Inc.
    19. Shishir Shakya & Jane E. Ruseski, 2023. "The effect of Prescription Drug Monitoring Programs on county‐level opioid prescribing practices and spillovers," Contemporary Economic Policy, Western Economic Association International, vol. 41(3), pages 435-454, July.
    20. Shyam Raman & Johanna Catherine Maclean & W. David Bradford & Coleman Drake, 2023. "Recreational cannabis and opioid distribution," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 747-754, April.

    More about this item

    JEL classification:

    • I10 - Health, Education, and Welfare - - Health - - - General
    • I12 - Health, Education, and Welfare - - Health - - - Health Behavior

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:jhecon:v:91:y:2023:i:c:s0167629623000516. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/inca/505560 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.